Skip to main content
. 2020 Mar 29;12(4):820. doi: 10.3390/cancers12040820

Figure 4.

Figure 4

Immunohistochemical analyses of EMPD lesions and normal epidermis. Skin specimens from a healthy donor (AC); UPN1, the case with the GAS6-FOXA1 fusion (DF); UPN2, the case with the FOXA1 promotor mutation (GI); and UPN11, a case with no detectable mutation (JL) stained with anti-FOXA1 (B,E,H,K) and anti-estrogen receptor alpha (C,F,I,L) antibodies (scale bars, 100 μm).